1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,100 | 2,240 | 14:14 | |
| 2,180 | 2,200 | 14:03 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.09. | 4DMEDICAL LIMITED: Cleansing Notice | 1 | ASX | ||
| 04.09. | 4DMEDICAL LIMITED: Application for quotation of securities - 4DX | - | ASX | ||
| 31.08. | Why 4DMedical shares could still rise 65% | 2 | The Motley Fool Australia | ||
| 28.08. | 4DMEDICAL LIMITED: Notification of Date of 2026 AGM | - | ASX | ||
| 28.08. | 4DMedical posts FY26 revenue growth as commercial deployment ramps up | 1 | The Market Online Australia | ||
| 28.08. | 4DMedical share price rises as FY26 revenue climbs, losses moderate | 2 | The Motley Fool Australia | ||
| 28.08. | 4DMEDICAL LIMITED: FY2026 Full year results | 3 | ASX | ||
| 4DMEDICAL Aktie jetzt für 0€ handeln | |||||
| 28.08. | 4DMEDICAL LIMITED: Appendix 4E - Preliminary Final Report | - | ASX | ||
| 14.08. | 4DMEDICAL LIMITED: Application for quotation of securities - 4DX | 1 | ASX | ||
| 14.08. | 4DMedical shares are up 670% - but why have they halved? | 2 | The Motley Fool Australia | ||
| 13.08. | 4DMEDICAL LIMITED: Cleansing Notice | 1 | ASX | ||
| 13.08. | 4DMEDICAL LIMITED: Application for quotation of securities - 4DX | 3 | ASX | ||
| 11.08. | Why this expert is betting against 4DMedical and DroneShield shares | 32 | The Motley Fool Australia | ||
| 10.08. | 4DMEDICAL LIMITED: Update - Proposed issue of securities - 4DX | 2 | ASX | ||
| 10.08. | RevealDx Secures $3.4 Million Investment From 4DMedical And Signs Global Distribution Agreement For RevealAI-Lung | 5 | pulse2.com | ||
| 07.08. | RevealDx Received $3.4M Investment From 4DMedical | 2 | FinSMEs | ||
| 31.07. | HotCopper Highlights, Week 31: Pilbara Minerals, BrainChip and 4DMedical spark fresh investor interest | 56 | The Market Online Australia | ||
| 31.07. | 4DMEDICAL LIMITED: Quarterly Activity Report and Appendix 4C | 4 | ASX | ||
| 28.07. | Up 1,250% in a year, why 4DMedical shares can keep charging higher | 6 | The Motley Fool Australia | ||
| 27.07. | Buy, hold, sell: Megaport, Orora, 4DMedical shares | 1 | The Motley Fool Australia |
1 2 3 4 5 Weiter >>
109 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,832 | +2,21 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,068 | +3,35 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 1,736 | -4,30 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,100 | +0,96 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 14,300 | +0,70 % | Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now | ||
| CO-DIAGNOSTICS | 1,140 | 0,00 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 9,056 | -0,96 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,345 | +0,21 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 7,070 | +0,28 % | Lifeward legt Termin für jährliche und außerordentliche Hauptversammlung 2026 fest | ||
| CLOVER HEALTH INVESTMENTS | 4,110 | +1,99 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| SENSEONICS | 7,800 | +1,30 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 0,755 | 0,00 % | Tempest Therapeutics: Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform | -Transaction complements Tempest's existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in... ► Artikel lesen | |
| NANO-X IMAGING | 0,687 | 0,00 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| IMUNON | 1,280 | +3,23 % | Imunon, Inc.: IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 |
Das Unternehmen 4DMEDICAL LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,140 (-6,31 %) liegt der Kurs bei 2,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu 4DMEDICAL LIMITED finden Sie auf Wallstreet Online.